More than a decade follow-up in patients with severe or difficult-to-treat asthma: The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) II-Reference-Cited by-同舟云学术

More than a decade follow-up in patients with severe or difficult-to-treat asthma: The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) II

Published:2018-05 Issue:5 Volume:141 Page:1590-1597.e9
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Chipps Bradley E.,Haselkorn Tmirah,Paknis Brandee,Ortiz Benjamin,Bleecker Eugene R.,Kianifard Farid,Foreman Aimee J.,Szefler Stanley J.,Zeiger Robert S.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference63 articles.

1. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma;Chung;Eur Respir J,2014

2. Utilization and costs of severe uncontrolled asthma in a managed care setting;Zeiger;J Allergy Clin Immunol Pract,2016

3. Healthcare costs and resource utilization of asthma in Germany: a claims data analysis;Jacob;Eur J Health Econ,2015

4. Medical cost burdens among nonelderly adults with asthma;Carrier;Am J Manag Care,2014

5. Assessment of asthma control and asthma exacerbations in the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) observational cohort;Chipps;Curr Respir Care Rep,2012

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding the impact of breathing pattern disorders in difficult-to-treat asthma;Expert Review of Respiratory Medicine;2024-09-13

2. Treating severe paediatric asthma with mepolizumab or omalizumab: a protocol for the TREAT randomised non-inferiority trial;BMJ Open;2024-08

3. Expert consensus on oral corticosteroids stewardship for the treatment of severe asthma in the Middle East and Africa;Respiratory Medicine;2024-07

4. Comparison of Asthma Phenotypes in Severe Asthma Cohorts (SARP, U-BIOPRED, ProAR and COREA) From 4 Continents;Allergy, Asthma & Immunology Research;2024

5. Real-life studies and registries of severe asthma: The advent of digital technology;Respiratory Medicine;2023-12